University of Chicago Medicine-Orland Park is a clinical research site located in Orland Park, Illinois, United States 60462.
Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Chicago Medicine-Orland Park has participated in 149 clinical trials with 119 currently active.
Therapeutic areas: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Orland Park
Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Chicago Medicine-Orland Park has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Chicago Medicine-Orland Park has 149 clinical trials on record, with 119 currently active. Their work covers Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
University of Chicago Medicine-Orland Park has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.